Advertisement

Topics

NICE backs NHS use of Nexavar for liver cancer, moving it away from CDF funding

02:57 EDT 10 Aug 2017 | thePharmaLetter

The UK’s National Institute for Health and Care Excellence (NICE) has today released a Final Appraisal…

Original Article: NICE backs NHS use of Nexavar for liver cancer, moving it away from CDF funding

NEXT ARTICLE

More From BioPortfolio on "NICE backs NHS use of Nexavar for liver cancer, moving it away from CDF funding"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...